期刊文献+

重庆市2003-2006年肺结核病耐药情况分析 被引量:31

Drug resistance of tuberculosis from 2003 to 2006 in Chongqing
暂未订购
导出
摘要 目的了解近3年重庆市耐药结核病流行现状,为耐药结核病的预防、控制提供依据。方法收集2003年6月至2006年6月间在重庆市结核病防治所及重庆市胸科医院就诊的肺结核病病例,按照《全国结核病诊断细菌学检验规程》,采用比例法对链霉素(Streptomycin,SM)、异烟肼(Isoniazide,INH)、利福平(Rifampicin,RFP)和乙胺丁醇(Ethambu-tol,EMB)共4种药物进行耐药性测定。结果1 089例痰培养阳性肺结核病例中,总耐药率和总耐多药率分别为27.7%、7.3%,平均耐药率顺位由高到低是SM(16.3%)、INH(14.0%)、RFP(10.7%)、EMB(4.8%);近3年RFP、EMB的耐药率和耐多药率呈逐年上升趋势。结论重庆市总体耐药水平接近全国平均水平,且近年耐多药率和RFP、EMB的耐药率呈上升趋势,复治、有服药史以及人均年可支配收入低于平均水平可能是结核病病例发生多耐药的相关因素。 Objective To explore the prevalence of drug-resistant tuberculosis in the past 3 years in Chongqing. and found basis for prevention, control and treatment drug-resistant tuberculosis. Methods Cases diagnosed as pulmonary tuberculosis were collected from Chongqing Chest Hospital and Institute of Tuberculosis Prevention and Treatment of Chongqing from June 2003 to June 2006. Proportion method was used to test the drug susceptibility of isoniazide (INH), rifampicin (RFP), streptomycin (SM) and ethambutol (EMB). Results All 1 089 cases with positive sputum culture were subjected. The total frequency of drug resistance and multi-drug resistance were respectively 27.7% and 7.3%. The drug-resistance rate of SM, INH, RFP and EMB were respectively 16.3% , 14.0% , 10.7% and 4.8%. The drug resistance and multi-drug resistance to RFP and EMB were increased gradually. The factors including retreatment, drug history, and lower annual disposable income per capita may promote the occurrence of multi-drug resistant tuberculosis. Conclusion The frequency of drug resistance to tuberculosis in Chongqing is close to the average of whole nation, and, multi-drug resistant rate and the RFP and EMB resistance rates are increasing in recent years. We need to establish and strengthen the continal monitoring on drug resistant tuberculosis in order to prevent and control it.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第12期1183-1185,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30700685)~~
关键词 耐药 结核病 相关因素 drug resistance tuberculosis relate factors
  • 相关文献

参考文献10

  • 1Cardoso E M. Multiple drug resistance : a threat for tuberculosis control [J], Rev Panam Salud Publica, 2004, 16(1) : 68 -73,
  • 2Lawn S D, Wilkinson R, Extensively drug resistant tuberculosis[ J ], BMJ, 2006, 333(7568) : 559 -560.
  • 3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:803
  • 4World Health Organization, Guidelines for surveillance of drug resistance in tuberculosis[ R]. 2nd ed. Geneva: WHO, 2003,
  • 5杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 6Zignol M, Hosseini M S, Wright A, et al. Global incidence of muhidrug- resistant tubereulosls[J], J Infect Dis, 2006, 194(4) : 479 -485.
  • 7Matos E D, Lemos A C, Bittencourt C, et al. Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia[J], Braz J Infect Dis, 2007, 11 (3) : 331 -338.
  • 8Zager E M, McNemey R, Multidrug-resistant tuberculosis [ J ], BMC Infect Dis, 2008, 8: 10.
  • 9Fattorini L, Migliori G B, Cassone A, Extensively drug-resistant (XDR) tuberculosis: an old and new threat[J]. Ann Ist Super Sanita, 2007, 43(4) : 317 -319.
  • 10梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:104

二级参考文献19

  • 1王甦民,刘宇红,姜广路.我国结核病耐药监测研究[J].中国防痨杂志,2003,25(z1):1-4. 被引量:8
  • 2李国明,周利平,刘勋,李爱国,李克国,袁方玉,杨占秋.湖北省不同年龄组和用药时间结核分枝杆菌耐药性的研究[J].武汉大学学报(医学版),2004,25(4):470-473. 被引量:5
  • 3沈国妙,查佳,徐琳,孙斌,桂晓红,王奕峰,梅建,高谦.结核分枝杆菌散在分布重复单位基因型分型法的应用研究[J].中华结核和呼吸杂志,2005,28(5):292-296. 被引量:28
  • 4结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:803
  • 5WHO/IUATLD.Guidelines for surveillance of drug resistance in tuberculosis.Int J Tuberc Lung Dis,1998,2:71-89.
  • 6DeRiemer K,García-García L,Bobadilla-del-Valle M,et al.Does DOTS work in populations with drug-resistant tuberculosis? Lancet,2005,365:1239-1245.
  • 7Durmaz R,Ozerol IH,Durmaz B,et al.Primary drug resistance and molecular epidemiology of Mycobacterium tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey.Microb Drug Resist,2003,9:361-366.
  • 8Lambregts-van Weezenbeek CS,Jansen HM,Veen J,et al.Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands:the truth behind the rates.Int J Tuberc Lung Dis,1998,2:296-302.
  • 9Department of Comuunicable Disease Surveillance and Response,World Health Organization.Anti-tuberculosis drug resistance in the world.Report no.2,prevalence trends.The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance[M].WHO/CDS/TB/2000:278.
  • 10Marcos A Espinal,Adalbert Laszlo,Lone Simonsen et al.Global trends in resistance to anti-tuberculosis drug resistance in tuberculosis[J].N Engl J Med,2001,344:1294-1303.

共引文献919

同被引文献271

引证文献31

二级引证文献209

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部